- Open Access
Development of a modularized two-step (M2S) chromosome integration technique for integration of multiple transcription units in Saccharomyces cerevisiae
Biotechnology for Biofuels volume 9, Article number: 232 (2016)
Saccharomyces cerevisiae has already been used for heterologous production of fuel chemicals and valuable natural products. The establishment of complicated heterologous biosynthetic pathways in S. cerevisiae became the research focus of Synthetic Biology and Metabolic Engineering. Thus, simple and efficient genomic integration techniques of large number of transcription units are demanded urgently.
An efficient DNA assembly and chromosomal integration method was created by combining homologous recombination (HR) in S. cerevisiae and Golden Gate DNA assembly method, designated as modularized two-step (M2S) technique. Two major assembly steps are performed consecutively to integrate multiple transcription units simultaneously. In Step 1, Modularized scaffold containing a head-to-head promoter module and a pair of terminators was assembled with two genes. Thus, two transcription units were assembled with Golden Gate method into one scaffold in one reaction. In Step 2, the two transcription units were mixed with modules of selective markers and integration sites and transformed into S. cerevisiae for assembly and integration. In both steps, universal primers were designed for identification of correct clones. Establishment of a functional β-carotene biosynthetic pathway in S. cerevisiae within 5 days demonstrated high efficiency of this method, and a 10-transcriptional-unit pathway integration illustrated the capacity of this method.
Modular design of transcription units and integration elements simplified assembly and integration procedure, and eliminated frequent designing and synthesis of DNA fragments in previous methods. Also, by assembling most parts in Step 1 in vitro, the number of DNA cassettes for homologous integration in Step 2 was significantly reduced. Thus, high assembly efficiency, high integration capacity, and low error rate were achieved.
Saccharomyces cerevisiae is a prominent model organism in the field of Synthetic Biology and Metabolic Engineering. It has already been used for heterologous production of fuel chemicals and valuable natural compounds, such as artemisinin [1, 2], taxol , ginsenosides , and tanshinones [5, 6]. More and more researchers are dedicated to establish complex heterologous biosynthetic pathways in S. cerevisiae [2, 7, 8]. Genes of the pathways need to be integrated into S. cerevisiae chromosome with regulation elements, such as promoters and terminators, in the form of transcription units . Thus, to establish a functional heterologous pathway with multiple genes, many DNA parts need to be integrated into the chromosome. Fast and convenient yeast genomic integration techniques are demanded urgently to meet the development of complex yeast engineering.
Based on the high efficiency of homologous recombination (HR) in S. cerevisiae, genomic modification of yeast mainly relies on homologous recombination in vivo. One of the most mature methods was developed by Huimin Zhao’s group [10, 11], whose DNA assembler method is able to assemble multiple DNA cassettes in S. cerevisiae, either on a plasmid or on a chromosome. To demonstrate their technique, zeaxanthin and aureothin biosynthetic pathways were successfully constructed and proved to be functional [10, 12, 13]. This technique allows assembly of multiple DNA fragments in a single-step fashion, which is efficient and time-saving compared with traditional restriction enzyme-dependent cut-and-paste manipulation method; therefore, it has been widely applied to DNA assembly and strain engineering. However, due to the nature of homologous recombination, assembly efficiency significantly decreases when the number of DNA parts increases [14, 15]. Meanwhile, error rate of assembly (proportion of incorrectly assembled constructs) increases with more DNA parts to be assembled [12, 16]. In addition, frequent designing and synthesis of the overlap sequences are required for the DNA assembler method, making the integration process laborious and costly. A novel technique is desired to overcome these problems.
Golden Gate assembly method as a rapid cloning strategy relies on Type IIs restriction enzymes, which is employed to assemble several DNA fragments into a vector simultaneously [17–19]. The type IIs restriction enzymes are able to cleave DNA fragments outside of their recognition site, resulting in 4 nt or 3nt overhangs (Fig. 1b). With rational design of the cleavage sites, two or more digested fragments can be ligated to form a seamless product without restriction recognition sites , which simplifies in vitro gene-cloning procedure. Similar as all the DNA assembly techniques, Golden Gate also suffers decreased efficiency as assembly parts increase.
In this work, we exploit an efficient DNA assembly and chromosomal integration method by combining Golden Gate method and yeast HR with modularized designed parts strategy. In this method, functional parts, including promoters, terminators, and gene coding sequences, were equipped with fixed terminal sequence for Golden Gate assembly. However, the assembled transcription units along with readymade selective markers and DNA homologous arms were integrated in pre-selected specific locus of chromosome. These modularized parts were used for integration of different genes, with which in vitro assembly step only required the preparation of cloning genes with specific adapter sequences. Two transcription units were designed to be assembled in one Golden Gate reaction with the specific design of paired head-to-head promoters [21, 22]. In the following step, assembled DNA fragments in step one were integrated into yeast chromosome also with readymade modularized parts, including selective markers and integration homologous arms in one step manner. In this work, we demonstrated application of this fast and easy method by integration of a four-gene β-carotene biosynthetic pathway into S. cerevisiae within 5 days. In addition, libraries of modularized promoters and terminators and scaffolds were constructed to enable integrations of more genes simultaneously. This novel technique has a great potential to be widely adopted in Synthetic Biology and Metabolic Engineering research for yeast species.
Results and discussion
Design and construction of modular parts for dual-transcription unit assembly (Step 1)
A functional transcription unit in S. cerevisiae includes at least a promoter (Pro), a gene coding sequence (Gene), and a terminator (Ter). For direct and simple assembly of transcription units, we have designed a three-module strategy as shown in Fig. 1. Each modular part was attached with dedicated adapter sequence for Golden Gate assembly. Two promoters were head-to-head fused with adapters and Type IIs restriction enzyme sites flanked away at the ends of this part (Fig. 1a). Accordingly, genes were PCR amplified to equip specific adapter sequences on both sides to connect with promoter and terminator parts (Fig. 1c). Two terminators were inserted into scaffold plasmid of Step 1 assembly, with dedicated homologous sequences (L1 and L2) lying on both sides of them, which were designed for assembly with modules in Step 2. Two back-to-back Type IIS restriction enzyme sites with protection sequence were inserted between the two terminators for assembly with other modules in Step 1 (Fig. 1b). For assembly reaction of the dual-transcription unit in Step 1, the previously mentioned three parts were digested with Type IIS restriction enzyme, such as BsaI or SapI, to expose the designed complementary DNA sticky ends. At last, the dual-transcription unit was formed by T4 DNA ligase with Golden Gate procedure.
For example, with BsaI as restriction enzyme (Fig. 1e), the cleavage site of BsaI was located behind its recognition sequence (5′-GGTCTC-3′). After digestion, a 4-bp overhang was exposed and recognition sequence was removed meanwhile. With ligation of these adapters, the product was formed as 5′ L1-Ter1-AGGT-Gene1-CATC-Pro1-Pro2-GTAC-Gene2-ATCG-Ter2-L2 3′ (Fig. 1d). Generally, yeast promoters extend 500–1500 bp upstream of the start codon, and terminators are defined as sequence 200–500 bp downstream of the stop codon. To obtain promoters and terminators to construct modular parts, we determined the boundary of them based on previous research of our lab and reports by other researchers. For easy storage and amplification, modular parts of Step 1 were constructed in the form of plasmids based on plasmid pMD-19T or pUC57. Type IIS restriction enzyme sites and adapter sequences were embedded in primers for application of coding sequences for assembly. P1, P2, until Pn were used to name promoter plasmids. Similarly, T1 to Tn were used to indicate terminator vectors, which were also the scaffolds for assembly of Step 1 parts. As illustrated in Table 2, five promoter plasmids and five terminator plasmids were constructed with ten promoters and ten terminators, the plasmid diagrams are shown in Additional file 1: Figures S1, S2. The promoters we employed in the method were the ones widely used in metabolic engineering of S. cerevisiae. Constitutive promoters with medium strength were mainly used in this work [23–25]. Terminators we selected were also common terminators that are reported and often used by other researchers. This set of parts allowed up to ten transcription units to be assembled into yeast genome simultaneously. Modular parts in these plasmids can be used repeatedly without change. To ligate with gene coding sequences, corresponding adapter sequences are inserted to both sides of them by PCR (adaptors for genes primers as shown in Table 1), which is the only necessary procedure to prepare genes for integration. Sequences of promoters and terminators are listed in Additional file 1: Tables S1, S2. Universal primers were designed to identify correct assembled plasmids (Additional file 1: Table S5).
Design and construction of modular parts for genomic integration (Step 2)
Step 2 was to assemble multiple dual-transcription units into S. cerevisiae chromosome, which was based on homologous recombination of multiple fragments in vivo (Fig. 2). The key of the recombination process was the dedicated overlap regions between assembly parts, designated as L1, L2 to Ln. As illustrated in Fig. 2, 5′ terminal of first dual-transcription unit overlapped with the 3′ terminal of selection marker cassette, whose 5′ end sequence shared homologous sequence with a target site of chromosome. Similarly, every part was designed to overlap with adjacent ones, while the 3′ terminal of the last unit overlapped with the target site of chromosome for integration. To simplify integration procedure and improve efficiency of homologous recombination, these 150-bp overlap sequences were designed to have least homology with S. cerevisiae genome by sequence analysis. Deployed homologous sequences L1 to L6 are shown in Additional file 1: Table S3. Since different chromosome regions showed diversity of transcription levels, Jens Nielsen’s group characterized 20 different integration sites of the S. cerevisiae genome by inserting lacZ as a reporter gene under the control of two different promoters and determined expression levels through enzyme activity measurement. Seventeen of these sites are solo long terminal repeats (solo LTRs), none of them was located in close proximity to an open reading frame. Higherβ-Galactosidase activity (The lacZ expression levels) of S. cerevisiae strains with integration sites of YORWΔ17, YORWΔ22, YPRCΔ15, and YPRCτ3 was observed. Thus, we selected three sites YORWΔ17, YORWΔ22, and YPRCΔ15 as our integration targets . As common yeast chromosomal integration method, these modular parts were co-transformed into S. cerevisiae by electroporation. PCR analysis was used to verify correctly integrated strains with designed universal primers.
Design of extra sets of adapters for increased compatibility of the M2S technique
In the process of Golden Gate assembly, presence of Type IIs restriction sites in gene coding sequence significantly decreases assembly efficiency. Alternative use of various Type IIs restriction enzymes, therefore restriction sites, is a strategy to avoid the existence of certain restriction sites in coding sequence and improve assembly efficiency. However, there are very limited Type IIs restriction enzymes available for Golden Gate assembly, namely BsaI, SapI, and BsmBI. Thus, the promoter parts and terminator parts were exhaustively designed to employ these enzyme sites with adaptor sequences accordingly (Table 1).
As listed in Table 2, we have constructed a series of promoter vectors and terminator vectors. Combinatory use of the vectors with various adapters guarantees assembly efficiency.
Integration of a four-gene β-carotene biosynthetic pathway with M2S technique
To illustrate the application of the M2S integration technique, β-carotene synthetic pathway was introduced into S. cerevisiae. This pathway includes carotenogenic genes CrtBY and CrtI from Xanthophyllomyces dendrorhous, whose expression enabled β-carotene production in yeast [27, 28]. In addition, overexpression of truncated 3-hydroxy-3-methylglutaryl-CoA reductase (tHMGR) from S. cerevisiae and GGPP synthase (GGPS) from Sulfolobus acidocaldarius could improve the supply of β-carotene intermediates, mevalonate, and GGPP . With our M2S integration technique, two dual-transcription units, L1- tTPI1- CrtBY-pTDH3-pADH1- CrtI-tPGI1-L2 and L2- tADH1-tHMG1- pPGK1 -pTEF2- SaGGPS-tCYC1-L3, were constructed as illustrated in previous text and Fig. 1. Each module, which was assembled in the form of a plasmid, included two transcription units and two homologous linkers. For colony PCR identification, F1 fragment was PCR amplified using the primer set L1F and L1R; F2 fragment with L2F and L3R, F3 fragment with pTDH3-F and SaGGPS-R, F4 fragment with pADH1-F and tHMG1-R, F5 fragment with pPGK1-F and CrtBY-R, and F6 fragment with pTEF2-F and CrtI-R (Fig. 3; Additional file 1: Table S5). In Step 1, the TU part construction and PCR verification took 2 days of work.
In Step 2, two readymade modules, site1-Ura3-L1 (Additional file 1: Figure S3) and L3-site2 (Additional file 1: Table S6), were used to integrate the two modules that constructed in Step 1. Gene YPF1(15 site, Additional file 1: Table S4) of yeast chromosome was used as target locus with Ura3 as selection marker. After electroporation and 2 days of incubation at 30 °C, hundreds of colonies appeared on the SC-Ura solid medium as shown in Additional file 1: Figure S4. The efficiency of transformation was calculated to be 2.751 × 103 CFU/μg DNA. Colonies that appeared in orange color were confirmed to produce β-carotene by HPLC, while white colonies did not (Fig. 4c). Thus, orange colonies represented correctly assembled and integrated strains. The ratio of correct clones in total clones was calculated to be 58.75 ± 6.9%, based on color indication. Experiments were done in triplet to obtain the average.
In order to further confirm the exact DNA sequences of correctly assembled clones, 20 orange colonies were picked for genomic DNA extraction. The obtained genomic DNA was used as PCR template for confirmation. As shown in Fig. 3a, six PCRs were designed to confirm correct assembled sequences of the modules, with primers targeting overlap regions and promoter regions. These PCRs were same as the ones for TU part verification. All tested orange colonies had the six PCR products as expected on agarose gel (Fig. 3b). To identify correct integration of β-carotene pathway, F1’ fragment (about 680 bp) was PCR amplified using the primer set FF1’ and RF1’, F2’ fragment (about 640 bp) was PCR amplified using the primer set FF2’ and RF2’. Primers FF1’ and RF2’ were designed to anneal with DNA sequence flanking YPRCΔ15 site on chromosome XVI; RF1’ was designed to anneal with Ura3 fragment; and FF2’ was designed to anneal with site2. Fragment F3’ was PCR amplified with primer set Y15site1F and Y15site2R, resulting a PCR product of 11.7 Kb, which was the whole assembled β-carotene pathway cassette. F4’ fragment was obtained with 15site1 (134)-F and pTDH3 (273)-R, and F5’ fragment with pTEF2 (211)-F and 15site2 (316)-R. PCR product F1’ to F5’ indicated correct assembly and integration of the four fragments (dual-transcription units, L1-Uras-site1 and site2-L3) on yeast chromosome (Fig. 4).
Integration of a ten-gene biosynthetic pathway with M2S technique
Five dual-transcription unit plasmids, L1-tTPI1-G1-pTDH3-pADH1-G2-tPGI1-L2, L2-tADH1-
G3-pPGK1-pTEF2-G4-tCYC1-L3, L3-tFBA1-G5-pTDH3-pADH1-G6-tPDC1-L4, L4- tRPS2-
G7-pPGK1-pTEF2-G8-tTDH1-L5, and L5-tCCW12-G9-pTDH3-pADH1-G10-tRPL9A-L6, were constructed with Golden Gate method as illustrated in previous text and Fig. 5a. These fragments were co-transformed with two modules, Site1-His3-L1 and L6-site2, into S. cerevisiae and selected on SC-His plates. Since the relevant research of this pathway was not ready to be published, furthermore, the sequence information was not relevant to the method we described in this article, all genes were represented as G1 to G10 without specific gene and sequence information.
Eleven colonies were picked for PCR identification (Fig. 5b). 7 primer sets (FF1 and RF1, FF2 and RF2, FF3 and RF3, FF4 and RF4, FF5 and RF5, FF6 and RF6, FF7 and RF7) were designed to analyze assembly and integration status on genome YORWΔ17 site. As shown in Fig. 5a, primers FF1 and RF7 were designed to anneal with DNA sequence flanking YORWΔ17 site on chromosome XV, RF1 was designed to anneal with site1 fragment, FF2 were designed to anneal with His3 fragment, while other primers were designed to anneal with the terminator fragments. Strains 4, 9, and 11 were identified to be assembled and integrated correctly (Fig. 5b), F1 to F7 represented corresponding PCR fragments from 7 primer sets, respectively. To further confirm that all ten genes (from G1 to G10) were included in the integration site, ten primer sets were designed to amplify within specific gene sequence, with PCR products around 100–200 bp range (Fig. 5c). Strains 4, 9, and 11 were all shown to contain the expected ten fragments. The control gene was ACT1.
Furthermore, to demonstrate the effectiveness of the ten-gene biosynthetic pathway, HPLC was used to analyze the culture of the 3 strains. Compared with standard, Strains 9 and 11 were confirmed to produce the target product (Fig. 5d).
An efficient DNA assembly and chromosomal integration method was created by combining homologous recombination (HR) in S. cerevisiae and Golden Gate method, designated as modularized two-step (M2S) technique. Two major assembly experiments are performed consecutively to integrate multiple transcription units simultaneously as illustrated in Figs. 1 and 2. In Step 1, Modularized scaffold containing a head-to-head promoter module and a pair of terminators was assembled with two genes. Thus, two transcription units were assembled with Golden Gate method into one scaffold in one reaction (Fig. 1). In Step 2, the two transcription units were mixed with modules of selective markers and integration sites and transformed into S. cerevisiae for assembly and integration (Fig. 2). Modules in Step 2 were readymade, which simplified the integration procedure without frequent designing and synthesis as previous methods. By assembling most parts in Step 1 in vitro, the number of DNA cassettes for homologous integration in Step 2 was significantly reduced. Thus, high assembly efficiency, high integration capacity, and low error rate were achieved. β-carotene synthesis pathway and a ten-gene pathway were integrated to have demonstrated the advantages of this technique.
Strain, plasmids, and media
Trans T1 Escherichia coli was used as the host for plasmid construction and amplification. S. cerevisiae 4742 (MATα, his3Δ1, leu2Δ0, lys2Δ0, MET15, ura3Δ0) was used as the host for DNA assembly and integration. pMD-19T plasmid serve as the vectors for assembly.
Construction of P1 (pTDH3-pADH) is an example of promoter module assembly. Head-to-head promoters pTDH3-pADH with Type IIs restriction enzyme sites flanking away were assembled by overlap PCR and then inserted in plasmid pMD19T-Amp at the region between M13F and M13R (Additional file 1: Figure S1). To construct terminator Plasmids, such as T1-(tTPI1-PGIt), terminator cassette L1-tTPI1-AGGTT (adapter)- BsaI-BsaI-AATCG (adapter)- PGIt-L2 was synthesized (GENEWIZ, China) and embedded in plasmid pMD19T-Amp or pUC57-kan. For integration module plasmids in Step 2, about 500 bp sequences of the N terminal and C terminal of the integration site were used as Site1 and Site2 for homologous integration. Site1- selective marker (URA3/HIS3/LEU2)-L1 cassette was constructed by overlap PCR and then connected with pUC57-Kan vector (Additional file 1: Figure S3) for storage (Additional file 1: Table S6). Site2 was similarly constructed (Additional file 1: Table S6).
Yeast YPD medium containing 1% yeast extract, 2% peptone supplied with 2% glucose was used to cultivate S. cerevisiae 4742 strain. Synthetic complete drop-out medium lacking uracil (SC-Ura) was used to select transformants. During plasmid construction, Trans T1 was grown in Luria broth: 10 g/L NaCl, 10 g/L tryptone, and 5 g/L yeast extract. Ampicillin (100 mg/L) and kanamycin (50 mg/L) were used where appropriate.
DNA assembly with Golden Gate method (Step 1)
The promoter and terminator plasmids were PCR amplified with universal primers to form corresponding modules. pTDH3-pADH1 was PCR amplified with primer set PMD-P1-FB and PMD-P1-RB, which was embedded with BsaI adapters for Golden Gate assembly. Alternatively, primer set PMD-P1-FS and PMD-P1-RS was embedded with SapI adapters for genes with native BsaI recognition sites. Similarly, terminator module was obtained by PCR amplification with T1 or T2 primer set. Coding sequences were PCR amplified with Golden Gate primers. Primers for XdCrtYB, XdCrtI, SaGGPS, and tHMG1 assembly are listed in Additional file 1: Table S5. Each fragment was mixed in equimolar amounts with 1.5 μL 10× T4 DNA ligase reaction buffer, 0.15 μL 100× bovine serum albumin, 1 μL T4 DNA ligase (2,000,000 U/mL), and 1 μL BsaI or BsmBI to a total volume of 15 μL. All reagents were purchased from New England Biolabs. The Golden Gate assembly was performed in a thermocycler as follows: 25 cycles of 37 °C for 3 min and 16 °C for 4 min, followed by 50 °C for 5 min and 80 °C for 5 min. 5 μL of assembly mixture was transformed into E. coli Trans T1 competent cells and incubated at 37 °C overnight on LB agar plates with Kan or Amp antibiotic.
To select correctly assembled plasmids, 10 colonies from LB agar plates with Kan or Amp antibiotic were randomly picked and boiled for PCR template. Colony PCRs were performed with 2 × Taq Master Mix (CWBiotech, China). F1 fragment was PCR amplified using the primer set L1F and L1R; F2 fragment with L2F and L3R, F3 fragment with pTDH3-F and SaGGPS-R, F4 fragment with pADH1-F and tHMG1-R, F5 fragment with pPGK1-F and CrtBY-R, and F6 fragment with pTEF2-F and CrtI-R (Fig. 3; Additional file 1: Table S5).
Selected colonies were inoculated into LB liquid medium, grown at 37 °C for 12 h, and purified with Axygen plasmid Miniprep kit for integration parts.
Integration of modular parts (Step 2)
For the genomic integration, transcription-unit modules, selective marker, and integration homologous arm modules were transformed into S. Cerevisiae 4742 cells via electroporation. Competent cells were prepared according to the following protocol: Single colonies were inoculated in 4 mL liquid YPD to OD600 = 0.6–1.0; and 2 mL of cells were collected via centrifugation at 10,000g for 1 min. Obtained cell pellet was washed twice using 1 mL ice-cold water and then incubated in 1 mL transformation reagent (10 mM LiAc, 10 mM DTT, 0.6 M sorbitol, 10 mM pH7.5 Tris–HCl) for 20 min at 25 °C. Conditioned cells were collected by centrifugation and washed twice using 1 mL ice-cold 1 M sorbitol buffer, then resuspended to a final volume of 100 μL in sorbitol buffer. Cells with 200 or 500 ng DNA were electroporated at 2.7 kV, 25 μF, 200 Ω (Bio-Rad, Hercules, CA) and incubated in 1 mL sorbitol buffer for 1–2 h at 30 °C, then plated on selective media for 2 days.
Measurement of β-carotene production and PCR confirmation of the correctly assembled pathways
β-carotene was extracted with a compound, that is mixed by methanol, acetonitrile, and dichloromethane (21:21:8), and was analyzed using high-performance liquid chromatography (Agilent Technologies Series 1200 system, Agilent, USA), 20 μL of extract was loaded onto the Agilent ZORBAX SB-C18 column (250 mm × 4.6 mm, 5 μm) and analyzed at 450 nm with a flow rate of 1.0 mL/min.
For PCR confirmation of transformants, single colonies were inoculated into 4 mL SC-Ura medium, then grown at 30 °C 250 rpm overnight. Cells were harvested by centrifugation; and genomic DNA was extracted by Yeast Gen DNA Kit (CWBiotech, China). 2 μL total DNA as template was PCR analyzed with 2 × Taq Master Mix (CWBiotech, China). F1 fragment was PCR amplified using the primer set L1F and L1R; F2 fragment with L2F and L3R, F3 fragment with pTDH3-F and SaGGPS-R, F4 fragment with pADH1-F and tHMG1-R, F5 fragment with pPGK1-F and CrtBY-R, F6 fragment with pTEF2-F and CrtI-R (the PCR assay result is the same as Fig. 3). To identify correct integration of β-carotene pathway, F1’ fragment was PCR amplified using the primer set FF1’ and RF1’, F2’ fragment was PCR amplified using the primer set FF2’ and RF2’. Primers FF1’ and RF2’ were designed to anneal with DNA sequence flanking YPRCΔ15 site on chromosome XVI; RF1’ was designed to anneal with Ura3 fragment; and FF2’ was designed to anneal with site2. Fragment F3’ was PCR amplified with primer set Y15site1F and Y15site2R. F4’ fragment was obtained with 15site1 (134)-F and pTDH3 (273)-R, and F5’ fragment with pTEF2 (211)-F and 15site2 (316)-R. All primers were designed be used as universal primers for verification.
PCR confirmation of TU plasmids of the 10 gene integration were similar as the 4 gene one.
yeast extract peptone dextrose medium
uracil synthetic drop-out media
Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R, Horning T, Tsuruta H, Melis DJ, Owens A, et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. P Natl Acad Sci USA. 2012;109(3):111–8.
Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature. 2006;440(7086):940–3.
Engels B, Dahm P, Jennewein S. Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. Metab Eng. 2008;10(3–4):201–6.
Dai Z, Liu Y, Zhang X, Shi M, Wang B, Wang D, Huang L. Metabolic engineering of Saccharomyces cerevisiae for production of ginsenosides. Metab Eng. 2013;20:146–56.
Dai ZB, Liu Y, Huang LQ, Zhang XL. Production of miltiradiene by metabolically engineered Saccharomyces cerevisiae. Biotechnol Bioeng. 2012;109(11):2845–53.
Zhou XL, Chan SW, Tseng HL, Deng Y, Hoi PM, Choi PS, Or PMY, Yang JM, Lam FFY, Lee SMY, et al. Danshensu is the major marker for the antioxidant and vasorelaxation effects of Danshen (Salvia miltiorrhiza) water-extracts produced by different heat water-extractions. Phytomedicine. 2012;19(14):1263–9.
Szczebara FM, Chandelier C, Villeret C, Masurel A, Bourot S, Duport C, Blanchard S, Groisillier A, Testet E, Costaglioli P, et al. Total biosynthesis of hydrocortisone from a simple carbon source in yeast. Nat Biotechnol. 2003;21(2):143–9.
Yan YJ, Kohli A, Koffas MAG. Biosynthesis of natural flavanones in Saccharomyces cerevisiae. Appl Environ Microb. 2005;71(9):5610–3.
Ramon A, Smith HO. Single-step linker-based combinatorial assembly of promoter and gene cassettes for pathway engineering. Biotechnol Lett. 2011;33(3):549–55.
Shao Z, Zhao H. DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Res. 2009;37(2):e16.
Shao Z, Luo Y, Zhao H. Rapid characterization and engineering of natural product biosynthetic pathways via DNA assembler. Mol BioSyst. 2011;7(4):1056–9.
Shao Z, Zhao H. DNA assembler: a synthetic biology tool for characterizing and engineering natural product gene clusters. Methods Enzymol. 2012;517:203–24.
Shao Z, Zhao H. Construction and engineering of large biochemical pathways via DNA assembler. Methods Mol Biol. 2013;1073:85–106.
Oldenburg KR, Vo KT, Michaelis S, Paddon C. Recombination-mediated PCR-directed plasmid construction in vivo in yeast. Nucleic Acids Res. 1997;25(2):451–2.
Raymond CK, Pownder TA, Sexson SL. General method for plasmid construction using homologous recombination. Biotechniques. 1999;26(1):134.
Li JW, Vederas JC. Drug discovery and natural products: end of era or an endless frontier? Biomeditsinskaia khimiia. 2011;57(2):148–60.
Agmon N, Mitchell LA, Cai YZ, Ikushima S, Chuang J, Zheng A, Choi WJ, Martin JA, Caravelli K, Stracquadanio G, et al. Yeast Golden Gate (yGG) for the efficient assembly of S. cerevisiae transcription units. Acs Synth Biol. 2015;4(7):853–9.
Werner S, Engler C, Weber E, Gruetzner R, Marillonnet S. Fast track assembly of multigene constructs using Golden Gate cloning and the MoClo system. Bioengineered. 2012;3(1):38–43.
Pingoud A, Fuxreiter M, Pingoud V, Wende W. Type II restriction endonucleases: structure and mechanism. Cell Mol Life Sci. 2005;62(6):685–707.
Engler C, Kandzia R, Marillonnet S. A one pot, one step, precision cloning method with high throughput capability. Plos ONE. 2008;3(11):e3647.
Cambray G, Guimaraes JC, Mutalik VK, Lam C, Mai QA, Thimmaiah T, Carothers JM, Arkin AP, Endy D. Measurement and modeling of intrinsic transcription terminators. Nucleic Acids Res. 2013;41(9):5139–48.
Mutalik VK, Guimaraes JC, Cambray G, Lam C, Christoffersen MJ, Mai QA, Tran AB, Paull M, Keasling JD, Arkin AP, et al. Precise and reliable gene expression via standard transcription and translation initiation elements. Nat Methods. 2013;10(4):354–60.
Da Silva NA, Srikrishnan S. Introduction and expression of genes for metabolic engineering applications in Saccharomyces cerevisiae. FEMS Yeast Res. 2012;12(2):197–214.
Hubmann G, Thevelein JM, Nevoigt E. Natural and modified promoters for tailored metabolic engineering of the yeast Saccharomyces cerevisiae. Methods Mol Biol. 2014;1152:17–42.
Nevoigt E, Kohnke J, Fischer CR, Alper H, Stahl U, Stephanopoulos G. Engineering of promoter replacement cassettes for fine-tuning of gene expression in Saccharomyces cerevisiae. Appl Environ Microb. 2006;72(8):5266–73.
Flagfeldt DB, Siewers V, Huang L, Nielsen J. Characterization of chromosomal integration sites for heterologous gene expression in Saccharomyces cerevisiae. Yeast. 2009;26(10):545–51.
Li Q, Sun Z, Li J, Zhang Y. Enhancing beta-carotene production in Saccharomyces cerevisiae by metabolic engineering. FEMS Microbiol Lett. 2013;345(2):94–101.
Verwaal R, Wang J, Meijnen JP, Visser H, Sandmann G, van den Berg JA, van Ooyen AJJ. High-level production of beta-carotene in Saccharomyces cerevisiae by successive transformation with carotenogenic genes from Xanthophyllomyces dendrorhous. Appl Environ Microb. 2007;73(13):4342–50.
Zhao J, Li Q, Sun T, Zhu X, Xu H, Tang J, Zhang X, Ma Y. Engineering central metabolic modules of Escherichia coli for improving beta-carotene production. Metab Eng. 2013;17:42–50.
JHF, BCH, and LSW developed the idea for the study. BCH and LSW designed the research, did the literature review, and prepared the manuscript. ZXL helped with strategy development and revision of the manuscript. LSW did the lab work, plasmid construction, strain cultivation, and product detection. DWT constructed the promoters, terminators library, and designed the L sequence library. BCH and LSW drafted the initial manuscript together and all authors contributed in analyzing the data and writing the draft. All authors read and approved the final manuscript.
This research was financially supported by the National High Technology Research and Development Program of China (2015AA020202), Tianjin Key Technology R&D program of Tianjin Municipal Science and Technology Commission (Y5M2121111), and Novo Nordisk-Chinese Academy of Sciences (NN-CAS) Research Fund (NNCAS-2015-2).
The authors declare that they have no competing interests.
Availability of supporting data
We provide support if necessary data for publication of the article. Supporting data are provided in Additional file 1.
Consent for publication
I hereby give Journal of Biotechnology for Biofuels the right and permission to publish this article.
This research was supported by the National High Technology Research and Development Program of China (2015AA020202), Tianjin Research Program of Application Foundation and Advanced Technology (15JCYBJC24200), and Novo Nordisk-Chinese Academy of Sciences (NN-CAS) Research Fund (NNCAS-2015-2).